GET /api/ms_vocab/?format=api&offset=32320&ordering=-name
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 43797,
    "next": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=32340&ordering=-name",
    "previous": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=32300&ordering=-name",
    "results": [
        {
            "accession": "DOID:14118",
            "name": "familial lipoprotein lipase deficiency",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:4332",
            "name": "familial hypophosphatemia",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:13810",
            "name": "familial hypercholesterolemia",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:11589",
            "name": "familial dysautonomia",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "EFO:0000492",
            "name": "familial combined hyperlipidemia",
            "definition": "['A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:0050424",
            "name": "familial adenomatous polyposis",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "UBERON:0003889",
            "name": "fallopian tube",
            "definition": "['Initial section of the oviduct through which the ova pass from the ovary to the uterus.']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0002994",
            "name": "FAK–/– cell",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0002995",
            "name": "FAK+/+ cell",
            "definition": "['disease: positive for FAK but null for p53, integrin signalling pathway']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0002993",
            "name": "FaDu cell",
            "definition": "['disease: squamous cell carcinoma']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:2222",
            "name": "factor X deficiency",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:2215",
            "name": "factor VII deficiency",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:2216",
            "name": "factor V deficiency",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "EFO:0000491",
            "name": "facioscapulohumeral muscular dystrophy",
            "definition": "['An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:1756",
            "name": "facial nerve disease",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "UBERON:0009891",
            "name": "facial mesenchyme",
            "definition": "['Mesenchyme that is part of a developing face.']",
            "term_type": "cell line"
        },
        {
            "accession": "UBERON:0003462",
            "name": "facial bone",
            "definition": "['A bone that is part of a facial skeleton [Automatically generated definition].']",
            "term_type": "cell line"
        },
        {
            "accession": "UBERON:0001456",
            "name": "face",
            "definition": "['A subdivision of the head that has as parts the layers deep to the surface of the anterior surface, including the mouth, eyes, and nose (when present). In vertebrates, this includes the facial skeleton and structures superficial to the facial skeleton (cheeks, mouth, eyeballs, skin of face, etc).']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:14499",
            "name": "Fabry disease",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0037255",
            "name": "FA2N-4 cell",
            "definition": "['FA2N-4 is a human hepatocyte cell line. Reference:  http://web.expasy.org/cellosaurus/CVCL_0267']",
            "term_type": "cell line"
        }
    ]
}